Propafenone
Rythmol (propafenone) is a small molecule pharmaceutical. Propafenone was first approved as Rythmol on 1989-11-27. It is used to treat atrial fibrillation, cardiac arrhythmias, and supraventricular tachycardia in the USA. The pharmaceutical is active against beta-1 adrenergic receptor. In addition, it is known to target potassium voltage-gated channel subfamily A member 5 and beta-2 adrenergic receptor.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Rythmol (generic drugs available since 2000-10-24)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Propafenone hydrochloride
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RYTHMOL SR | GSK | N-021416 RX | 2003-09-04 | 3 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
propafenone hydrochloride | ANDA | 2023-04-17 |
rythmol | New Drug Application | 2018-11-02 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
atrial fibrillation | EFO_0000275 | D001281 | I48.0 |
cardiac arrhythmias | EFO_0004269 | D001145 | I49.9 |
supraventricular tachycardia | HP_0004755 | D013617 | I47.1 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
5 clinical trials
View more details

Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Candidiasis | D002177 | B37 | — | 1 | — | — | — | 1 | |
Tinea pedis | D014008 | EFO_0007512 | B35.3 | — | 1 | — | — | — | 1 |
Eczema | D004485 | HP_0000964 | L30.9 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Psoriasis | D011565 | EFO_0000676 | L40 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atopic dermatitis | D003876 | EFO_0000274 | L20 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | PROPAFENONE |
INN | propafenone |
Description | Propafenone is an aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias. It has a role as an anti-arrhythmia drug. It is a secondary amino compound, a secondary alcohol and an aromatic ketone. It is a conjugate base of a propafenone(1+). |
Classification | Small molecule |
Drug class | antiarrhythmics (propafenone derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1 |
Identifiers
PDB | — |
CAS-ID | 54063-53-5 |
RxCUI | — |
ChEMBL ID | CHEMBL631 |
ChEBI ID | 63619 |
PubChem CID | 4932 |
DrugBank | DB01182 |
UNII ID | 68IQX3T69U (ChemIDplus, GSRS) |
Target
Agency Approved
Alternate
KCNA5
KCNA5
ADRB2
ADRB2
Organism
Homo sapiens
Gene name
KCNA5
Gene synonyms
NCBI Gene ID
Protein name
potassium voltage-gated channel subfamily A member 5
Protein synonyms
cardiac potassium channel, HPCN1, insulinoma and islet potassium channel, potassium channel 1, potassium channel, voltage gated shaker related subfamily A, member 5, potassium voltage-gated channel, shaker-related subfamily, member 5, Voltage-gated potassium channel HK2, voltage-gated potassium channel protein Kv1.5, Voltage-gated potassium channel subunit Kv1.5
Uniprot ID
Mouse ortholog
Kcna5 (16493)
potassium voltage-gated channel subfamily A member 5 (Q9Z1R6)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3,277 documents
View more details
Safety
Black-box Warning
Black-box warning for: Propafenone hydrochloride, Rythmol
Adverse Events
Top Adverse Reactions

Mock data
Subscribe for the real data
Subscribe for the real data
784 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more